Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000886000 | SCV001029482 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001553557 | SCV001774450 | benign | not specified | 2021-07-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000886000 | SCV001899256 | benign | not provided | 2020-05-20 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001553557 | SCV002065517 | benign | not specified | 2021-03-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000886000 | SCV002544816 | benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | APPL1: BP4, BP7, BS1, BS2 |
Fulgent Genetics, |
RCV002507568 | SCV002808829 | likely benign | Maturity-onset diabetes of the young type 14 | 2021-11-29 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV002507568 | SCV004564725 | benign | Maturity-onset diabetes of the young type 14 | 2023-08-24 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000886000 | SCV005302042 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003930664 | SCV004740698 | benign | APPL1-related disorder | 2019-04-25 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |